Last Updated: 17 Oct 2024
Executive Summary
Moolec Science SA (MLEC) is a science-based ingredient company focused on producing animal proteins in plants through Molecular Farming. The company has a market capitalization of $33.41 million and is currently trading at $0.92 per share. Analysts have a "Buy" rating on the stock with a target price of $3.00.
Company Overview
Moolec Science SA is headquartered in Luxembourg and was founded in 2016. The company's mission is to provide sustainable and affordable animal proteins to the global food market. Moolec Science SA's technology platform enables the production of animal proteins in plants, which has the potential to reduce the environmental impact of meat production and address the growing demand for alternative proteins.
Fundamental Analysis
Moolec Science SA's financial performance has been mixed in recent quarters. The company reported revenue of $5.63 million in the most recent quarter, an increase of 68.3% year-over-year. However, the company also reported a net loss of $8.18 million, or $0.19 per share. Moolec Science SA has a negative EBITDA margin of -1.3% and a negative return on assets of -19.2%.
Technical Analysis
The technical analysis of Moolec Science SA's stock price shows that the stock is currently trading below its 50-day and 200-day moving averages. The stock has been in a downtrend since reaching a high of $3.25 in March 2023. The relative strength index (RSI) is currently at 30.00, which indicates that the stock is oversold.
Short Term Outlook
The short-term outlook for Moolec Science SA's stock is mixed. The company's financial performance has been improving in recent quarters, but the stock price has been in a downtrend. The stock is currently trading below its 50-day and 200-day moving averages, which indicates that the trend is likely to continue in the short term.
Long Term Outlook
The long-term outlook for Moolec Science SA's stock is positive. The company's technology platform has the potential to revolutionize the way that animal proteins are produced. If Moolec Science SA can successfully commercialize its technology, the company could become a major player in the alternative protein market.
Analyst Recommendations
Analysts have a "Buy" rating on Moolec Science SA's stock with a target price of $3.00. The analysts believe that the company's technology has the potential to disrupt the alternative protein market and that the stock is undervalued at current levels.
